XML 32 R25.htm IDEA: XBRL DOCUMENT

Development, Commercialization and Supply Agreements (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Product Approval

The Company received approval of VASCEPA under the MARINE and REDUCE-IT indications in the following countries:


Country		MARINE		REDUCE-IT		Launch Date
Lebanon		March 2018		August 2021		June 2018
United Arab Emirates		July 2018		October 2021		February 2019
Qatar		December 2019		April 2021		N/A
Bahrain		April 2021		April 2022		N/A
Kuwait		December 2021		March 2023		September 2023
Saudi Arabia		March 2022		June 2023		September 2023

Changes in Balances of Contract Assets and Liabilities and Revenues Recognized

The following table presents changes in the balances of the Company’s contract assets and liabilities during the three months ended March 31, 2024 and 2023:


In thousands	Balance at Beginning of Period				Additions				Deductions				Balance at End of Period
Three months ended March 31, 2024:
Contract assets	$	—			$	—			$	—			$	—
Contract liabilities:
Deferred revenue	$	4,850			$	—			$	(401	)		$	4,449

Three months ended March 31, 2023:
Contract assets	$	—			$	—			$	—			$	—
Contract liabilities:
Deferred revenue	$	15,346			$	—			$	(445	)		$	14,901

During the three months ended March 31, 2024 and 2023, the Company recognized the following revenues as a result of changes in the contract asset and contract liability balances in the respective periods:


In thousands	Three months ended March 31,
Revenue recognized in the period from:	2024				2023
Amounts included in contract liability at the beginning of the period	$	401			$	445